BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19442829)

  • 1. Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.
    Harvey BK; Chou J; Shen H; Hoffer BJ; Wang Y
    Neurotoxicology; 2009 May; 30(3):436-44. PubMed ID: 19442829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9-Cis retinoic acid protects against methamphetamine-induced neurotoxicity in nigrostriatal dopamine neurons.
    Reiner DJ; Yu SJ; Shen H; He Y; Bae E; Wang Y
    Neurotox Res; 2014 Apr; 25(3):248-61. PubMed ID: 23884514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents.
    Chou J; Luo Y; Kuo CC; Powers K; Shen H; Harvey BK; Hoffer BJ; Wang Y
    Neuroscience; 2008 Jan; 151(1):92-103. PubMed ID: 18082966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain.
    Wang Y; Chang CF; Morales M; Chiang YH; Harvey BK; Su TP; Tsao LI; Chen S; Thiemermann C
    J Neurosci; 2003 Aug; 23(21):7958-65. PubMed ID: 12944527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.
    Yu SJ; Airavaara M; Shen H; Chou J; Harvey BK; Wang Y
    Psychopharmacology (Berl); 2012 Jun; 221(3):479-92. PubMed ID: 22160138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
    Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice.
    Chou J; Harvey BK; Ebendal T; Hoffer B; Wang Y
    Acta Neurochir Suppl; 2008; 101():93-8. PubMed ID: 18642641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a binge-like dosing regimen of methamphetamine on dopamine levels and tyrosine hydroxylase expressing neurons in the rat brain.
    Moreira da Silva Santos A; Kelly JP; Dockery P; Doyle KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():303-309. PubMed ID: 30296469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity to dopamine neurons after the serial exposure to alcohol and methamphetamine: Protection by COX-2 antagonism.
    Blaker AL; Rodriguez EA; Yamamoto BK
    Brain Behav Immun; 2019 Oct; 81():317-328. PubMed ID: 31228610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine alters reference gene expression in nigra and striatum of adult rat brain.
    He Y; Yu S; Bae E; Shen H; Wang Y
    Neurotoxicology; 2013 Dec; 39():138-45. PubMed ID: 24042092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats.
    Zhang X; Dong F; Mayer GE; Bruch DC; Ren J; Culver B
    Neuroscience; 2007 Dec; 150(4):950-8. PubMed ID: 17988800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
    Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
    Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
    Koike K; Hashimoto K; Fukami G; Okamura N; Zhang L; Ohgake S; Koizumi H; Matsuzawa D; Kawamura N; Shimizu E; Iyo M
    Neuropharmacology; 2005 Mar; 48(3):391-7. PubMed ID: 15721171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
    Alfinito PD; Wang SP; Manzino L; Rijhsinghani S; Zeevalk GD; Sonsalla PK
    J Neurosci; 2003 Nov; 23(34):10982-7. PubMed ID: 14645494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons.
    Ahmadi FA; Linseman DA; Grammatopoulos TN; Jones SM; Bouchard RJ; Freed CR; Heidenreich KA; Zawada WM
    J Neurochem; 2003 Nov; 87(4):914-21. PubMed ID: 14622122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.